Fulvestrant as a reference antiestrogen and estrogen receptor (ER) degrader in preclinical studies: treatment dosage, efficacy, and implications on development of new ER-targeting agents.
Ontology highlight
SUBMITTER: Wang G
PROVIDER: S-EPMC7508469 | biostudies-literature |
REPOSITORIES: biostudies-literature
ACCESS DATA